Ten-Year Data Demonstrate Ocrevus Treatment Reduced Disability in Individuals with Multiple Sclerosis – Practical Neurology
According to long-term study results, earlier treatment with Ocrevus (ocrelizumab; Genentech, South San Francisco, CA) resulted in greater reductions